Researchers from the Moscow Institute of Physics and
Technology and their colleagues from Shemyakin-Ovchinnikov
Institute of Bioorganic Chemistry and Prokhorov General Physics
Institute of the Russian Academy of Sciences have developed a
breakthrough technology to resolve a key problem that has prevented
the introduction of novel drugs into clinical practice for decades.
The new solution prolongs blood circulation for virtually any
nanomedicine, boosting its therapeutic efficiency. The Russian
researchers’ study was published in Nature Biomedical Engineering
and featured in the journal’s News & Views
section.
